The company opened a 200,000-square-foot facility in Kakegawa, Japan to serve the needs of domestic and global clinical trial sponsors.

MilliporeSigma surveyed 250 biopharmaceutical executives on how their companies will manage new risks associated with the changing biopharmaceutical landscape.

The new company is the product of a merger with Formex.

The wearable devices for the delivery of biologic products are now being manufactured and will be tested in clinical trials in the near future, according to the company.

The collaboration will provide GMP manufacturing ahead of future clinical studies.

A new 20,000-L microbial biologics facility in Ireland will be operational by 2018 for Fujifilm Diosynth's contract development and manufacturing customers.

Uncertainty about the demand for a biologic medication can be partly mollified with some well-planned capacity outsourcing, contends a new report by ORC International sponsored by Patheon.

An article in Nature Reviews Drug Delivery reports the clinical success rates of biologics, and these numbers differ from those recently highlighted in a similar BIO study.

The agency reiterated its earlier decision to require suffixes in biosimilar naming, but was unclear on suffix meaning.

The agency published a report on fostering the development of advanced therapy medicinal products.

Results of the HERITAGE study were announced at the 2016 American Society of Clinical Oncology meeting.

Industry experts discuss common considerations and recent technological advancements in blow-fill-seal technology.

Process analytical technology paved the way for continuous manufacturing.

With technology advances, continuous manufacturing shows steady progress to more widespread adoption.

FDA approved dalizumab a monoclonal antibody for the treatment of multiple sclerosis.

New pharmacovigilance activities seek to support the creation of guidelines for safe switching from innovator products to biosimilars.

Production of kilogram-scale batches of synthetic molecules for early-stage development are now available to US customers.

As the battle for ownership over the use of CRISPR to edit DNA heats up, some of the CRISPR pioneers refocus their efforts to demonstrate the technology’s applications for editing RNA.

During its May 2016 meeting the CHMP recommended the approval of six medications in the EU, including three generic drugs, treatments for hepatitis C, and Type 2 diabetes.

The Start-up Hub is designed to give start-up companies the opportunity to network at Pharmapack.

The company opened its 62,000 square foot facility, called the BioProcess Innovation Center, in Triangle Park, NC.

The company opened a new sales office located in Seoul, South Korea.

The company expanded its topicals capacity with an investment in the Becomix RW30 model homogenizer.

FDA issues a warning letter to Megafine Pharma Limited for data integrity violations.

Pharma has voiced strong opposition against Britain’s departure from the EU.

Jazz will acquire Celator for approximately $1.5 billion.

FDA approved Probuphine, the first buprenorphine implant approved in the United States for the treatment of opioid dependence.

The company received a warning letter at its Latina facility in Sermoneta, Italy following a May 2015 inspection.